A5072678615- Thermoregulation and physiological responses
- Adrenal Hormones and Disorders
- Traditional Chinese Medicine Studies
- Pituitary Gland Disorders and Treatments
- Neurological and metabolic disorders
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
- Hormonal and reproductive studies
- Thyroid Disorders and Treatments
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
Thomas Jefferson University
2021-2024
Icahn School of Medicine at Mount Sinai
1998
City University of New York
1998
Abstract Aims Tirzepatide is a first‐in‐class combination glucose‐dependent insulinotropic polypeptide (GIP) receptor agonist and glucagon‐like peptide 1 (GLP1‐RA) approved for treatment of adults with type 2 diabetes mellitus (T2DM) chronic weight management. The aim this analysis was to assess the real‐world efficacy tirzepatide in patients T2DM. Methods This retrospective observational study evaluated T2DM from large urban academic medical centre who received at least 3 months continuous...
Abstract Disclosure: F.L. Thelmo: None. M. Murugesh: B. Simon: Introduction: The autoantibody GAD (anti-glutamic acid decarboxylase) is highly associated with Type 1 diabetes (T1DM) and Latent Autoimmune Diabetes in Adulthood (LADA). If detected before the onset of overt diabetes, typically 80% patients abnormal glucose tolerance progress to insulin deficiency need for treatment after 5 years.[1] Stiff Person Syndrome (SPS) also antibodies, but SPS, antibodies are believed be different...
Abstract Introduction: Polyglandular Autoimmune Syndrome Type II (PAS-2) is a rare disorder characterized by two or more endocrine diseases (primary adrenal insufficiency, autoimmune thyroid disease, type 1 diabetes). Of these, the most common thyropathy, followed Diabetes (1). These endocrinopathies rarely have concurrent onset. This case reports 22-year-old male, recently recovered from severe pneumonia, who presented to Emergency Department in acute crisis and was diagnosed with PAS-2....